Skip to main navigation Skip to search Skip to main content

A phase III double-blinded, randomised, placebo-controlled study investigating the efficacy and safety of NTI164 in children and young adults with Autism Spectrum Disorder.

Project: Research

Project Details

StatusActive
Effective start/end date17/09/26 → 16/09/31

Clinical Trial Phase

  • Phase III (a & b)